# Telmisartan Versus Losartan in Kidney Transplantation

> **NCT01224860** · PHASE2 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 20 (actual)

## Conditions studied

- Renal Transplant

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Losartan

## Key facts

- **NCT ID:** NCT01224860
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-06
- **Final completion:** 2014-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01224860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01224860, "Telmisartan Versus Losartan in Kidney Transplantation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01224860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*